These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33426096)

  • 1. Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs.
    Melgaço JG; Brito E Cunha D; Azamor T; da Silva AMV; Tubarão LN; Gonçalves RB; Monteiro RQ; Missailidis S; da Costa Neves PC; Ano Bom APD
    J Immunol Res; 2020; 2020():8827670. PubMed ID: 33426096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery.
    Basheer M; Saad E; Laskar O; Schuster O; Rechnitzer H; Zisman-Rozen S; Azoulay D; Assy N
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
    Schijns V; Lavelle EC
    Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
    Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
    Front Immunol; 2020; 11():569760. PubMed ID: 33362758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Based Therapy for COVID-19.
    Esmaeilzadeh A; Jafari D; Tahmasebi S; Elahi R; Khosh E
    Adv Exp Med Biol; 2021; 1318():449-468. PubMed ID: 33973194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.
    Tandon S; Aggarwal A; Jain S; Shukla S; Chaudhary S
    Protein J; 2020 Dec; 39(6):631-643. PubMed ID: 33034824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions.
    Shah M; Woo HG
    Mol Cells; 2021 Jun; 44(6):408-421. PubMed ID: 34059561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
    Keam S; Megawati D; Patel SK; Tiwari R; Dhama K; Harapan H
    Rev Med Virol; 2020 Sep; 30(5):e2123. PubMed ID: 32648313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic approaches to curtail COVID-19.
    Owji H; Negahdaripour M; Hajighahramani N
    Int Immunopharmacol; 2020 Nov; 88():106924. PubMed ID: 32877828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell responses and therapies against SARS-CoV-2 infection.
    Toor SM; Saleh R; Sasidharan Nair V; Taha RZ; Elkord E
    Immunology; 2021 Jan; 162(1):30-43. PubMed ID: 32935333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy.
    Iovino L; Thur LA; Gnjatic S; Chapuis A; Milano F; Hill JA
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2.
    Sajna KV; Kamat S
    Cytotherapy; 2021 Feb; 23(2):101-110. PubMed ID: 32988772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and mechanistic insights into drug repurposing for combating COVID-19.
    Asrani P; Tiwari K; Eapen MS; McAlinden KD; Haug G; Johansen MD; Hansbro PM; Flanagan KL; Hassan MI; Sohal SS
    Int J Biochem Cell Biol; 2022 Jan; 142():106114. PubMed ID: 34748991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serology-based therapeutic strategy in SARS-CoV-2-infected patients.
    Garcia-Muñoz R; Farfán-Quiroga G; Ruiz-de-Lobera N; Feliu J; Anton-Remirez J; Nájera Irazu MJ; Lisa Catón V; Oteo-Revuelta JA
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108214. PubMed ID: 34649116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing immunotherapy to combat COVID-19: A modern snake oil or silver bullet?
    Gunjegaonkar SM; Shanmugarajan TS; Arunsundar M; Arjun UVNV; Devi K; Wankhede SB; Ravichandiran V
    Therapie; 2021; 76(4):335-345. PubMed ID: 34238584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapies and immunomodulatory approaches in clinical trials - a mini review.
    Iqbal Yatoo M; Hamid Z; Rather I; Nazir QUA; Bhat RA; Ul Haq A; Magray SN; Haq Z; Sah R; Tiwari R; Natesan S; Bilal M; Harapan H; Dhama K
    Hum Vaccin Immunother; 2021 Jul; 17(7):1897-1909. PubMed ID: 33577374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.
    Raman R; Patel KJ; Ranjan K
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.